Ron Bose, MD, PhD, from the Siteman Cancer Center, discusses the prevalence of HER2 gene mutations in patients diagnosed with breast cancer.
Ron Bose, MD, PhD
Advertisement
Articles by Ron Bose, MD, PhD
Advertisement
Latest Updated Articles
Dr. Ron Bose on HER2 Gene Mutations in Breast CancerMarch 8th 2013
Advertisement
Advertisement
Trending on OncLive
1
Targeted Therapies, ADCs, and Oral SERD Combos Expand Treatment Possibilities Across Breast Cancer Settings
2
Head and Neck Oncologists Highlight Practice-Informing Research From ASCO 2026
3
Dr Galsky on the Current Roles of Biomarkers in Bladder Cancer
4
Sonrotoclax Plus Zanubrutinib Yields High Undetectable MRD Rates in Treatment-Naive CLL/SLL
5